Rachel Mcminn

Affiliations

  • Chief Executive Officer at Neurogene Inc. (NGNE), 2025-03-29
  • Chief Strategy Officer at Intercept Pharmaceuticals Inc (ICPT), 2017-10-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NGNE $20.40 47,500 $969,000.00 1,297,859 2024-11-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ICPT $58.89 283 $16,666.78 16,875 2017-10-02 Filing
ICPT $123.12 130 $16,005.29 17,158 2017-07-31 Filing
ICPT $121.78 257 $31,297.46 17,288 2017-07-03 Filing
ICPT $113.12 114 $12,895.69 17,545 2017-05-01 Filing
ICPT $115.00 257 $29,554.31 17,659 2017-04-03 Filing